Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Proteomics|September 10, 2010
Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedureChafika Mazouni, Keith Baggerly, David Hawke, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancerJae K Lee, Charles Coutant, Young-Chul Kim, et al.Nature Reviews. Genetics|September 15, 2010
Tackling the widespread and critical impact of batch effects in high-throughput dataJeffrey T Leek, Robert B Scharpf, Héctor Corrada Bravo, et al.Cancer Research|November 3, 2004
From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studiesYuhui Hu, Hongxia Sun, Jeffrey Drake, et al.Journal of Proteome Research|January 11, 2011
Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFRVaibhav Chumbalkar, Khatri Latha, YeoHyeon Hwang, et al.Breast Cancer Research : BCR|August 21, 2004
Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expressionMartin C Abba, Jeffrey A Drake, Kathleen A Hawkins, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|May 24, 2005
High-resolution whole-organ mapping with SNPs and its significance to early events of carcinogenesisTomasz Tuziak, Joon Jeong, Tadeusz Majewski, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 22, 2005
Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathwaysJai-Hyun Kim, Tomasz Tuziak, Limei Hu, et al.European Urology Focus|February 12, 2018
Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) TestShizhen Zhang, Yan Wang, Jolanta Bondaruk, et al.Oncotarget|December 23, 2015
NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanismsHailing Yang, Partha Das, Yinhua Yu, et al.Pageof 5